IRMD Stock Cash Flow Statements

IRadimed Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

IRadimed Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30

operating activities:
net income	5,773,961	4,687,429	5,146,778	5,049,491	4,901,224	4,136,533	4,539,686	5,067,180	4,179,844	3,406,066	3,673,617	3,427,104	3,241,053	2,486,713	3,892,667	2,576,261	1,469,694	1,386,849	637,414	1,074,646	-2,112,270	1,769,211	3,241,683	2,454,870	2,088,841	1,845,565	1,707,013	2,400,273	1,354,968	841,196	183,638	192,393	357,073	-233,340	1,140,800	1,560,483	2,231,251	2,282,011	2,404,706	1,867,148	1,770,571	1,487,495	270,821	237,357
adjustments to reconcile net income to net cash from operating activities:
allowance for credit losses	-17,979	-14,910	-3,137	-109,925	56,734	-38,207
benefit from excess and obsolete inventory	45,239	-37,718	-114,499	97,426	65,713	39,001																													7,643	-67	11,664	74,946	-52,382	61,315	33,714	8,442	25,360	7,040
depreciation & amortization	207,476	194,122	194,866	197,571
loss on disposal of property and equipment			-1	0	3,665	207
stock-based compensation	730,618	826,064	656,835	629,964	609,096	628,641	551,064	533,749	568,453	533,643	426,555	393,188	121,003	453,360	391,784	361,836	358,012	347,741	317,906	416,525	2,658,632	568,958	548,535	455,641	468,436	382,353	402,355	503,556	442,081	416,327	719,285	913,275	445,379	376,424	53,856	192,456	1,204,406	391,183	306,884	331,149	307,054	275,031	220,182	171,599
deferred income taxes	133,533	129,582	-105,823	125,830	-1,635,032	917,373	-69,042	-37,350	-1,144,172	78,656	284,230	-82,185	-92,905	-52,043	109,512	123,912	1,288	288,895	79,603	1,144,508	-801,707	-32,472	-622,826	-9,503	-23,474	59,048
(gain) on maturities of investments
changes in operating assets and liabilities:
accounts receivable	1,802,037	-2,134,549	-188,810	1,698,484	1,016,723	-764,322	498,857	-1,678,349	460,884	1,560,519	-2,669,905	-2,275,241	-1,914,861	-1,380,681	-897,395	-369,255	682,075	9,032	-308,701	251,513	1,342,971	1,404,704								490,147				47,115									-786,111
inventory	-751,217	-120,010	1,847,838	699,521	485,635	93,052	-1,337,578	-1,917,827	-3,029,401	-1,183,364	-405,164	-316,290	-670,411	82,909	-48,595	148,767	174,873	-668,361	779,551	297,619	-799,078	-560,996
prepaid income taxes							0	0	-493,393	747,486	-292,260	2,333,715	393,689	617,201	-406,499	45,860	-571,971	103,383				-901,001
prepaid expenses and other current assets	-917,001	505,726	-564,839	69,586	17,537	157,483	-522,432	-97,623	133,002	-75,434	611,967	145,245	-81,485	-369,791	-374,639	810,095	-912,995	-560,508	-455,926	31,065	-135,954	-538,093											56,732	2,018							60,516	72,488
other assets	1,510	-7,097	-14,699	4,022	-3,534	-3,252	48,949	-123,274	380,608	160,940	-404,884	-3,759	-29,062	39,481	3,110	-6,978	-1,634	32,059	-24,288	-14,497	34,212	-60,614												3,665
accounts payable	-689,064	693,639	-387,798	289,056	-122,556	-640,320	-736,084	-1,189,415	1,603,615	105,448	1,087,634	52,960	-201,962	186,340	47,490	61,984	-3,255	-75,805	65,048	-149,032	-52,939	-266,644	-144,491	114,898	-196,290	375,202	-169,757										-44,181	219,531	88,578	-18,401	153,698	152,418	-11,068	-27,033
accrued payroll and benefits	943,503	-1,505,114	487,530	379,527	760,478	-630,882	484,912	-42,452	716,007	-1,255,254	522,118	80,605	391,692	-937,085	400,574	403,912	777,391	-482,099	72,010	-50,732	70,129	-542,834	-70,440				-8,661				73,919	336,348											325,854	68,044
other accrued taxes	67,664	93,982	-30,690	35,951	21,199	33,297	18	-114,273	158,909	-63,332	-21,791	-91,660	112,909	-17,854	49,061	-31,198	44,859	-26,388	-19,215	-384,929	381,299	-469,750												501	-72,187
warranty reserve	2,621	331	66	-1,454	4,627	-2,433	7,159	4,825	4,461	6,988	-1,257	-5,482	-5,964	-2,147	-2,127	2,479	12,080	6,394	2,995	-1,313	-1,313	7,924	4,264	2,440						10,414	12,025			23,169	2,763	2,060	1,544	457	-28,999	3,900	0	31,255	12,254	-1,331
deferred revenue	789,003	547,207	-50,497	-49,336	257,887	-269,106	208,572	770,443	-287,081	-76,298	983,398	-199,748	-135,348	-117,726	-265,319	-1,089,597	1,152,619	250,359	-131,860	-135,640	-53,261	308,559	162,648	166,383	33,239	338,078		-360,961			312,291	-151,125	613,440	170,026	463,921	772,170	393,154	94,673	154,021	-646,116	587,591	405,967	-52,195	-149,308
other current liabilities	0	-150,000					0	0	0	250,000	-136,927	-1,513	-1	-7,994																						7,172
net cash from operating activities	7,746,261	4,292,092	5,987,069	9,115,714	6,638,527	3,883,153	3,912,480	1,392,684	3,513,756	4,646,092	3,038,844	3,938,461	1,639,219	1,426,187	3,366,043	3,378,341	3,570,691	943,081	2,496,068	1,334,197	790,596	1,196,635	3,948,859	3,138,242	2,480,428	665,204	3,542,373	727,933	1,521,819	1,583,890	1,401,119	1,907,910			2,223,693	3,420,757	1,330,017	2,431,853	2,566,720	2,343,213	1,683,210	1,056,187	-901,391	1,239,483
capex	-2,635,746	-3,697,468	-2,790,174	-3,810,022	-1,134,271	-270,566	-531,903	-308,086	-204,591	-6,395,930	-258,136	-192,948	-188,583	-183,352	-91,022	-150,760	-108,225	-132,318	-93,720	-48,725	-133,965	-166,593	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0
free cash flows	5,110,515	594,624	3,196,895	5,305,692	5,504,256	3,612,587	3,380,577	1,084,598	3,309,165	-1,749,838	2,780,708	3,745,513	1,450,636	1,242,835	3,275,021	3,227,581	3,462,466	810,763	2,402,348	1,285,472	656,631	1,030,042	3,948,859	3,138,242	2,480,428	665,204	3,542,373	727,933	1,521,819	1,583,890	1,401,119	1,907,910			2,223,693	3,420,757	1,330,017	2,431,853	2,566,720	2,343,213	1,683,210	1,056,187	-901,391	1,239,483
investing activities:
purchases of property and equipment	-2,635,746	-3,697,468	-2,790,174	-3,810,022	-1,134,271	-270,566	-531,903	-308,086	-204,591	-6,395,930	-258,136	-192,948	-188,583	-183,352	-91,022	-150,760	-108,225	-132,318	-93,720	-48,725	-133,965	-166,593
capitalized intangible assets	-187,992	-219,832	-266,555	-201,462	-135,499	-208,237	-100,913	-130,937	-173,723	-161,084	-213,540	-363,240	-233,856	-241,342	-89,200	-69,824	-58,795	-41,615	-9,462	-61,747	-58,752	-63,782
net cash from investing activities	-2,823,738	-3,917,300	-3,056,729	-4,011,484	-1,269,770	-478,803	-632,816	-439,023	-378,314	-6,557,014	-471,676	-556,188	77,561	-424,694	259,778	-220,584	782,980	-173,933	300,533	-110,472	287,283	-230,375	935,469	1,369,080	339,306	557,333	1,074,428			211,719		-36,557
financing activities:
dividends paid	-2,161,628	-2,161,522	-1,901,298	-1,900,487	-1,899,644	-7,975,997	0	0	0	-13,222,907		0	0	-12,559,127
proceeds from exercises of stock options			26,322	0			169,403	2				74,758	1	71,948		62,920	20,235	2,460		931,732	468,810	322,179
taxes paid related to the net share settlement of equity awards	-95,994	-116,297	-542,508	-17,832	-63,944	-63,876	-431,993	-31,372	-97,107	-49,876		-22,417	-5,726	-67,380		-8,766	-15,874	-38,707		-63,490	-725,385	-133,872
net cash from financing activities	-2,257,622	-2,277,819	-2,417,484	-1,918,319	-1,960,292	-8,039,873	-262,590	-31,370	-89,768	-13,272,783	-198,457	52,341	-5,725	-12,554,559	2,157	54,154	4,361	-36,247	-277,492	868,242	-256,575	188,307	-39,955	1,708,092	-82,197	434,232	-288,277	998,667	127,936	91,548									1,127,150	837,653	57,030	304,270	270,228
net increase in cash and cash equivalents											2,368,712	3,434,613	1,711,055	-11,553,066	3,627,978	3,211,911	4,358,032	732,901	2,519,109	2,091,967	821,304	1,154,567	4,844,373	6,215,414	2,737,537	1,656,769	4,328,524	2,368,285	1,237,746	1,887,157	-200,329									3,101,707	1,654,015	1,319,363
cash and cash equivalents, beginning of period	0	52,233,907	0	0	0	49,762,198	0	0	0	57,960,864		0	0	61,999,550		0	0	50,068,728		0	0	43,481,781		0	0	28,027,688		0	0	18,205,976		0	0	17,713,871		0	0	19,368,114		0	0	9,454,150		0
cash and cash equivalents, end of period	2,664,901	50,330,880	512,856	3,185,911	3,408,466	45,126,674	3,017,074	922,291	3,045,675	42,777,158		3,434,613	1,711,055	50,446,484		3,211,911	4,358,032	50,801,629		2,091,967	821,304	44,636,348		6,215,414	2,737,537	29,684,457		2,368,285	1,237,746	20,093,133		1,605,688	-656,024	17,456,641		3,938,204	-3,441,574	15,507,432		3,101,707	1,654,015	10,773,513		13,852,871
supplemental disclosure of cash flow information:
dividends declared not yet paid
cash paid for income taxes	2,337,082	9,000	2,055,000	1,448,523	2,818,709	189,595	1,215,556	1,380,000			954,363	0	749,000	8,137	-313,722	320,000	958,527	5,195					0	0			84,554	928,110			33,064	3,615			0	727,329	2,501,093	164,300	300,000	600,000	1,797,000	5,000	177,856	175,000
rou asset and liability adjustment			0	0
operating and short-term lease payments recorded within cash flow provided by operating activities	188,629	178,749	204,022	205,548	204,008	203,354	182,662	168,166	162,548	161,814		107,708	129,034	128,083		125,563	120,915	118,067
accrued income taxes		583,408
net decrease in cash and cash equivalents		-1,903,027			3,408,466	-4,635,524	3,017,074	922,291	3,045,675	-15,183,706
rou asset recognized in exchange for new lease obligation							-1	1	2	227,980
net increase/decrease in cash and cash equivalents
depreciation and amortization						226,088	205,375	189,897	187,358	182,550	-692,905	435,477	494,176	433,925	386,600	340,132	348,297	331,794	339,012	330,989	324,039	344,784	280,728	288,921	285,595	387,081	260,118	14,722	402,416	427,747	338,033	771,682	114,954	84,069	64,017	61,538	61,830	60,914	60,233	57,445	54,955	51,309	49,418	45,176
allowance for doubtful accounts
gain on disposal of property and equipment							2	8,683					0	-4,894
proceeds from maturities of investments												0
change in allowance for doubtful accounts								-34,075	-9,883	180,788	46,649	34,748	17,151	4,219	14,443	312	-2,607	1,728	-13,902	1,757	3,273	36,756	3,806	12,408	-6,326	21,450	-10,313	14,009	3,295	8,842
change in benefit from excess and obsolete inventory								52,545	80,693	86,690	26,510	9,403	7,570	12,254	66,486	-1,247	54,970	-1,992	-116,387	-6,167	-92,767	128,143	-56,293	-11,193	-4,929	120,529	13,889	24,320	12,570	61,011	31,178	14,362
loss on maturities of investments												0																21,386						5,099
(gain) on disposal of property and equipment
disposal of property and equipment
gain on maturity of investments
proceeds from maturity of investments															440,000	0			403,715	0			1,165,000	1,472,000	400,000	650,000	1,175,000	900,000	580,000	250,000	0	225,000	769,954	1,500,050	500,037	1,772,011	2,003,092	300,000
dividends
proceeds from stock option exercises																													139,156	95,924		1	16,373	33,086		126,758	16,667	73,590		121,747	7,223	191,837
taxes paid for net share settlement of restricted stock units
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
right-of-use asset recognized in exchange for new lease obligation																							0	0	0	3,182,724
operating and short-term lease payments recorded within cash flow from operating activities																			108,032	106,979	107,796	107,081	107,269	107,571	106,677	106,659
(gain) loss on disposal of property and equipment
other																			7,868				0
proceeds from stock option and warrant exercises
taxes paid for the net share settlement of restricted stock units
gain on maturities of investments																0										3,826
other current liability
right-of-use asset recognized in exchange for a new lease obligation																0
(gain) loss on maturity of investments
purchases of investments
(prepaid) accrued income taxes
(gain) loss on maturities of investments
(prepaid ) accrued income taxes
write-off of non-trade accounts receivable																															0	0
prepaid income taxes, net of accrued income taxes																							-264,860	183,439
purchases of treasury stock
proceeds from exercises of stock options and warrants
proceeds from exercises of stock options and underwriters’ warrants																										456,739
excess tax benefit on the exercise of stock options
loss on maturity of investments																																				33,789
income tax benefits credited to equity																																			53,122	284,337	209,515	56,579	850,449	715,906	49,807	112,433
accrued income taxes, net of prepaid income taxes																													29,039	410,045				201,143	309,181	324,475	-962,455	1,246,506		-152,630	-705,058	962,908		49,755
impairment of intangible assets																																							0	0	0	55,433
income tax benefit credited to equity
loss on investments
bad debt expense																																			-6,464	-14,448	17,862	15,686	-12,175	-42,938	14,864	43,802
gain on sale or maturity of investments
repayment of officer note payable
proceeds from the issuance of common stock pursuant to initial public offering																																											0
payment of initial public offering costs
loss on sale of investments																																						7,026
other accrued liabilities
proceeds from sale of investments																																											0
net increase in cash and equivalents																																											-8,659,709	13,852,871
other accrued current liabilities
patent and software costs

We provide you with 20 years of cash flow statements for IRadimed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IRadimed stock. Explore the full financial landscape of IRadimed stock with our expertly curated income statements.

The information provided in this report about IRadimed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.